Literature DB >> 21664819

Pseudomonas aeruginosa: all roads lead to resistance.

Elena B M Breidenstein1, César de la Fuente-Núñez, Robert E W Hancock.   

Abstract

Pseudomonas aeruginosa is often resistant to multiple antibiotics and consequently has joined the ranks of 'superbugs' due to its enormous capacity to engender resistance. It demonstrates decreased susceptibility to most antibiotics due to low outer membrane permeability coupled to adaptive mechanisms and can readily achieve clinical resistance. Newer research, using mutant library screens, microarray technologies and mutation frequency analysis, has identified very large collections of genes (the resistome) that when mutated lead to resistance as well as new forms of adaptive resistance that can be triggered by antibiotics themselves, in in vivo growth conditions or complex adaptations such as biofilm growth or swarming motility.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21664819     DOI: 10.1016/j.tim.2011.04.005

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  334 in total

1.  Sodium houttuyfonate in vitro inhibits biofilm dispersion and expression of bdlA in Pseudomonas aeruginosa.

Authors:  Tianming Wang; Weifeng Huang; Qiangjun Duan; Jian Wang; Huijuan Cheng; Jing Shao; Fang Li; Daqiang Wu
Journal:  Mol Biol Rep       Date:  2018-12-03       Impact factor: 2.316

2.  The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility.

Authors:  Veronica N Kos; Maxime Déraspe; Robert E McLaughlin; James D Whiteaker; Paul H Roy; Richard A Alm; Jacques Corbeil; Humphrey Gardner
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

3.  Role of intracellular proteases in the antibiotic resistance, motility, and biofilm formation of Pseudomonas aeruginosa.

Authors:  Lucía Fernández; Elena B M Breidenstein; Diana Song; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

4.  Expression, purification, crystallization and preliminary X-ray analysis of Pseudomonas aeruginosa AlgL.

Authors:  Francis Wolfram; Kritica Arora; Howard Robinson; Ana Mirela Neculai; Patrick Yip; P Lynne Howell
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-04-21

5.  Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients With Pseudomonas aeruginosa Infection.

Authors:  Sara Y Tartof; Jennifer L Kuntz; Lie H Chen; Rong Wei; Laura Puzniak; Yun Tian; Theresa M Im; Harpreet S Takhar; Sanjay Merchant; Thomas Lodise
Journal:  JAMA Netw Open       Date:  2018-10-05

6.  Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.

Authors:  Jocelyn Y Ang; Nahed Abdel-Haq; Frank Zhu; Abrar K Thabit; David P Nicolau; Michael J Satlin; David van Duin
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

7.  A PhoPQ-Regulated ABC Transporter System Exports Tetracycline in Pseudomonas aeruginosa.

Authors:  Lin Chen; Kangmin Duan
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

8.  Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram-Negative Bacteria.

Authors:  Jinshan Jin; Ying-Hsin Hsieh; Jianmei Cui; Krishna Damera; Chaofeng Dai; Arpana S Chaudhary; Hao Zhang; Hsiuchin Yang; Nannan Cao; Chun Jiang; Martti Vaara; Binghe Wang; Phang C Tai
Journal:  ChemMedChem       Date:  2016-10-18       Impact factor: 3.466

Review 9.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

Review 10.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.